Adma Biologics Inc’s recently made public that its President and CEO Grossman Adam S unloaded Company’s shares for reported $0.45 million on Apr 15 ’25. In the deal valued at $21.46 per share,21,000 shares were sold. As a result of this transaction, Grossman Adam S now holds 2,055,850 shares worth roughly $48.74 million.
Then, Grossman Adam S sold 21,000 shares, generating $397,320 in total proceeds. Upon selling the shares at $18.92, the President and CEO now owns 2,061,850 shares.
Before that, Grossman Adam S bought 84,000 shares. Adma Biologics Inc shares valued at $1,571,640 were divested by the Director and Officer at a price of $18.71 per share.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.
Price Performance Review of ADMA
On Monday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock jump 0.81% to $23.71. Over the last five days, the stock has lost -3.26%. Adma Biologics Inc shares have risen nearly 38.25% since the year began. Nevertheless, the stocks have risen 255.47% over the past one year. While a 52-week high of $25.67 was reached on 04/28/25, a 52-week low of $6.65 was recorded on 03/04/25. SMA at 50 days reached $19.52, while 200 days put it at $17.98.
Levels Of Support And Resistance For ADMA Stock
The 24-hour chart illustrates a support level at 23.28, which if violated will result in even more drops to 22.86. On the upside, there is a resistance level at 24.15. A further resistance level may holdings at 24.60. The Relative Strength Index (RSI) on the 14-day chart is 62.20, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.03, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 28.53%. Stochastics %K at 69.33% indicates the stock is a holding.
The most recent change occurred on June 04, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
